Abstract PS5-01-08: Development of the HER2DX Predictor of Brain Metastasis in Advanced HER2-Positive Breast Cancer Treated with First-Line THPRodrigo Sánchez-Bayona, M. Jarzab, Sandra Cobo et al.|Clinical Cancer Research|2026Cited by 0
Abstract PS4-07-06: Independent validation of TNBCDX, a 15-gene genomic risk stratification tool for early-stage triple-negative breast cancerF. Brasó-Maristany, M. Alva, P. Tolosa et al.|Clinical Cancer Research|2026Cited by 0